{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:14:10Z","timestamp":1793643250713,"version":"4.5.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jpsychires.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T08:42:02Z","timestamp":1459500122000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts"],"prefix":"10.1016","volume":"78","author":[{"given":"Trisha","family":"Suppes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kroger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Pikalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Loebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A\u00a0rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00213-002-1147-6","article-title":"Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression","volume":"163","author":"Bech","year":"2002","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S1092852913000102","article-title":"A\u00a0systematic review of the evidence for the treatment of acute depression in bipolar I disorder","volume":"18","author":"Cerullo","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib11","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.08m04301","article-title":"Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD","volume":"70","author":"Goldberg","year":"2009","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1399-5618.2009.00735.x","article-title":"Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States","volume":"11","author":"Goldstein","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2011.10.033","article-title":"Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the international AMSP project between 1994 and 2009","volume":"136","author":"Greil","year":"2012","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib16","series-title":"ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare Publication (ADM)","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-244X-12-153","article-title":"Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP","volume":"12","author":"Haeberle","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jad.2013.10.054","article-title":"Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011","volume":"155","author":"Hooshmand","year":"2014","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4088\/JCP.11r06978","article-title":"Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation\/combination strategies in treatment partial responders\/nonresponders with major depressive disorder?","volume":"73","author":"Iovieno","year":"2012","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib23","series-title":"Advances in Treatment of Bipolar Disorders","article-title":"Treatment of acute bipolar deprssion","author":"Ketter","year":"2015"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-002-0999-0","article-title":"Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation","volume":"161","author":"Licht","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2011.10060907","article-title":"Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study","volume":"168","author":"Meltzer","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"132","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4088\/JCP.08m04905","article-title":"Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo controlled trial","volume":"70","author":"Nakamura","year":"2009","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S1092852914000285","article-title":"Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies","volume":"20","author":"Nasrallah","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib38","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40345-015-0026-0","article-title":"Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania","volume":"3","author":"Ostacher","year":"2015","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib43","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.2004.00409.x","article-title":"Strategies for improving treatment of bipolar disorder: integration of measurement and management","author":"Sachs","year":"2004","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib46","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4088\/JCP.09m05934","article-title":"Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Sachs","year":"2011","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","article-title":"Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics","volume":"47","author":"Selle","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib49","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"issue":"Suppl.\u00a020","key":"10.1016\/j.jpsychires.2016.03.012_bib50","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A\u00a0rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies","volume":"28","author":"Thase","year":"2008","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.03.012_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.03.012_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616300504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616300504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T21:21:31Z","timestamp":1536873691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616300504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"alternative-id":["S0022395616300504"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.03.012","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}